Advertisement
Product › Details
sarilumab
Next higher product group | IL-6 receptor antibody | |
Status | 2016-01-08 registration pending | |
Organisation | Sanofi S.A. (Euronext: SAN, Nasdaq: SNY) | |
Group | Sanofi (Group) [since May 2011] | |
Organisation 2 | Regeneron Pharmaceuticals Inc. (Nasdaq: REGN) | |
Group | Regeneron (Group) | |
Record changed: 2023-07-10 |
Advertisement
More documents for therapeutic antibody
- [1] Crescendo Biologics Ltd.. (7/24/23). "Press Release: Crescendo Biologics Secures $32m and Announces Expansion of CB307 Phase 1b Trial in PSMA+ Solid Tumours". Cambridge....
- [2] Dualyx N.V.. (5/15/23). "Press Release: Dualyx Raises €40 Million to Progress Treg Therapies for Autoimmune Diseases into the Clinic". Ghent....
- [3] Calida Therapeutics SAS. (4/6/23). "Press Release: French Biotech Calida Therapeutics Launches with Seed Funding, Leveraging US Academic Research in Thrombo-inflammatory Disorders". Paris....
- [4] Lys Therapeutics SAS. (3/15/23). "Press Release: Lys Therapeutics Secures Funding from The Michael J. Fox Foundation to Accelerate the Development of Its Drug Candidate in Parkinson’s Disease". Lyon & Caen....
- [5] Sanofi S.A.. (3/13/23). "Press Release: Sanofi to Acquire Provention Bio, Adding to Portfolio TZIELD, the First Disease-modifying Treatment for the Delay of Stage 3 Type 1 Diabetes (T1D)". Paris & Red Bank, NJ....
- [6] Lys Therapeutics SAS. (11/14/22). "Press Release: Lys Therapeutics Announces a Seed Round of 5.5 Million Euros to Prepare Future Clinical Studies for Its First-in-class Monoclonal Antibody targeting neurovascular and neurodegenerative disorders". Lyon &...
- [7] RQ Biotechnology Ltd.. (5/17/22). "Press Release: RQ Bio Launches with Goal to Transform Treatment and Prevention of Viral Infectious Diseases Through Antibody Technologies". London....
- [8] Alentis Therapeutics AG. (11/9/21). "Press Release: Alentis Therapeutics Announces Board Appointments". Basel....
- [9] Pierre Fabre S.A.. (10/7/21). "Press Release: Talem Therapeutics Announces Multi-Target Antibody Discovery Research Collaboration with Pierre Fabre". Victoria, BC & Castres....
- [10] Xenothera. (6/29/21). "Press Release: French Biotech Xenothera Accelerates Its Development with Fundraising of 20 Million Euros". Nantes....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top